223 related articles for article (PubMed ID: 37150867)
21. Differences in racial/ethnic disparities in patient care experiences between prostate cancer survivors and males without cancer: A SEER-CAHPS study.
Pandit AA; Gressler LE; Halpern MT; Kamel M; Payakachat N; Li C
J Geriatr Oncol; 2023 Jul; 14(6):101554. PubMed ID: 37320932
[TBL] [Abstract][Full Text] [Related]
22. Racial disparities in prostate cancer-specific mortality in men with low-risk prostate cancer.
Mahal BA; Aizer AA; Ziehr DR; Hyatt AS; Choueiri TK; Hu JC; Hoffman KE; Sweeney CJ; Beard CJ; D'Amico AV; Martin NE; Kim SP; Trinh QD; Nguyen PL
Clin Genitourin Cancer; 2014 Oct; 12(5):e189-95. PubMed ID: 24861952
[TBL] [Abstract][Full Text] [Related]
23. Changing Incidence of Metastatic Prostate Cancer by Race and Age, 1988-2015.
Dall'Era MA; deVere-White R; Rodriguez D; Cress R
Eur Urol Focus; 2019 Nov; 5(6):1014-1021. PubMed ID: 29735368
[TBL] [Abstract][Full Text] [Related]
24. Disparities in Hispanic/Latino and non-Hispanic Black men with low-risk prostate cancer and eligible for active surveillance: a population-based study.
Katz JE; Chinea FM; Patel VN; Balise RR; Venkatramani V; Gonzalgo ML; Ritch C; Pollack A; Parekh DJ; Punnen S
Prostate Cancer Prostatic Dis; 2018 Nov; 21(4):533-538. PubMed ID: 29988097
[TBL] [Abstract][Full Text] [Related]
25. Racial/ethnicity differences in endorsing influential factors for prostate cancer treatment choice: An analysis of data from the personal patient profile-prostate (P3P) I and II trials.
Trinh QD; Hong F; Halpenny B; Epstein M; Berry DL
Urol Oncol; 2020 Mar; 38(3):78.e7-78.e13. PubMed ID: 31883873
[TBL] [Abstract][Full Text] [Related]
26. Geographic Distribution of Racial Differences in Prostate Cancer Mortality.
Fletcher SA; Marchese M; Cole AP; Mahal BA; Friedlander DF; Krimphove M; Kilbridge KL; Lipsitz SR; Nguyen PL; Choueiri TK; Kibel AS; Trinh QD
JAMA Netw Open; 2020 Mar; 3(3):e201839. PubMed ID: 32232449
[TBL] [Abstract][Full Text] [Related]
27. Ethnic heterogeneity and prostate cancer mortality in Hispanic/Latino men: a population-based study.
Chinea FM; Patel VN; Kwon D; Lamichhane N; Lopez C; Punnen S; Kobetz EN; Abramowitz MC; Pollack A
Oncotarget; 2017 Sep; 8(41):69709-69721. PubMed ID: 29050235
[TBL] [Abstract][Full Text] [Related]
28. Racial Differences in Time to Breast Cancer Surgery and Overall Survival in the US Military Health System.
Eaglehouse YL; Georg MW; Shriver CD; Zhu K
JAMA Surg; 2019 Mar; 154(3):e185113. PubMed ID: 30673075
[TBL] [Abstract][Full Text] [Related]
29. Racial and Ethnic Disparities in Lung Adenocarcinoma Survival: A Competing-Risk Model.
Wu X; Wang Y; Lin X; Wang Z; Xu J; Lv W; Hu J
Clin Lung Cancer; 2020 May; 21(3):e171-e181. PubMed ID: 31787547
[TBL] [Abstract][Full Text] [Related]
30. Variation in racial/ethnic disparities in COVID-19 mortality by age in the United States: A cross-sectional study.
Bassett MT; Chen JT; Krieger N
PLoS Med; 2020 Oct; 17(10):e1003402. PubMed ID: 33079941
[TBL] [Abstract][Full Text] [Related]
31. Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancer.
Mahal BA; Ziehr DR; Aizer AA; Hyatt AS; Sammon JD; Schmid M; Choueiri TK; Hu JC; Sweeney CJ; Beard CJ; D'Amico AV; Martin NE; Lathan C; Kim SP; Trinh QD; Nguyen PL
Urol Oncol; 2014 Nov; 32(8):1285-91. PubMed ID: 24846344
[TBL] [Abstract][Full Text] [Related]
32. Does Veteran Status Mitigate Racial Disparities in Prostate Cancer Screening? Analysis of Prostate Specific Antigen Screening Patterns in the 2018 Behavioral Risk Factor Surveillance System Data.
Alkhatib K; Labban M; Briggs L; Nguyen DD; Herzog P; Cole AP; Haag A; Trinh QD
J Urol; 2022 May; 207(5):993-1000. PubMed ID: 34967663
[TBL] [Abstract][Full Text] [Related]
33. Independent and Joint Effects of Testosterone Replacement Therapy and Statins use on the Risk of Prostate Cancer Among White, Black, and Hispanic Men.
Lopez DS; Polychronopoulou E; Tsilidis KK; Khera M; Su LJ; Fowke JH; Peek MK; Kuo YF; Markides K; Canfield S
Cancer Prev Res (Phila); 2021 Jul; 14(7):719-728. PubMed ID: 33879532
[TBL] [Abstract][Full Text] [Related]
34. Racial treatment trends in localized/regional prostate carcinoma: 1992-1999.
Underwood W; Jackson J; Wei JT; Dunn R; Baker E; Demonner S; Wood DP
Cancer; 2005 Feb; 103(3):538-45. PubMed ID: 15612083
[TBL] [Abstract][Full Text] [Related]
35. Race has no impact on prostate cancer-specific mortality, when comparing patients with similar risk of other-cause mortality: An analysis of a population-based cohort.
Tinsley SA; Finati M; Stephens A; Chiarelli G; Cirulli GO; Williams E; Morrison C; Richard C; Hares K; Sood A; Buffi N; Lughezzani G; Bettocchi C; Salonia A; Briganti A; Montorsi F; Carrieri G; Rogers C; Abdollah F
Cancer; 2024 May; ():. PubMed ID: 38804713
[TBL] [Abstract][Full Text] [Related]
36. Differences in Nutrient Intake and Diet Quality Between Non-Hispanic Black and Non-Hispanic White Men in the United States.
Thompson TL; Singleton CR; Springfield SE; Thorpe RJ; Odoms-Young A
Public Health Rep; 2020; 135(3):334-342. PubMed ID: 32250708
[TBL] [Abstract][Full Text] [Related]
37. Racial/ethnic disparities in early-onset colorectal cancer: implications for a racial/ethnic-specific screening strategy.
Acuna-Villaorduna AR; Lin J; Kim M; Goel S
Cancer Med; 2021 Mar; 10(6):2080-2087. PubMed ID: 33641251
[TBL] [Abstract][Full Text] [Related]
38. Disparities in Infant Mortality by Race Among Hispanic and Non-Hispanic Infants.
Rice WS; Goldfarb SS; Brisendine AE; Burrows S; Wingate MS
Matern Child Health J; 2017 Jul; 21(7):1581-1588. PubMed ID: 28197819
[TBL] [Abstract][Full Text] [Related]
39. Racial disparities in prostate cancer outcome among prostate-specific antigen screening eligible populations in the United States.
Mahal BA; Chen YW; Muralidhar V; Mahal AR; Choueiri TK; Hoffman KE; Hu JC; Sweeney CJ; Yu JB; Feng FY; Kim SP; Beard CJ; Martin NE; Trinh QD; Nguyen PL
Ann Oncol; 2017 May; 28(5):1098-1104. PubMed ID: 28453693
[TBL] [Abstract][Full Text] [Related]
40. The Effect of Other-cause Mortality Adjustment on Access to Alternative Treatment Modalities for Localized Prostate Cancer Among African American Patients.
Bandini M; Preisser F; Nazzani S; Marchioni M; Tian Z; Mazzone E; Graefen M; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
Eur Urol Oncol; 2018 Aug; 1(3):215-222. PubMed ID: 31102624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
